Index(Alphabet)
Alphabet

Index

A

page

AMY → Amylase (AMY)

3Amylase (AMY)3
3

A/G ratio1

Amylase isoenzymes

ABC classification, LA

5Amylase, type P, quantitative

3

ABO blood groups test

88(β-) Amyloid 1-42/1-40 ratio

96

ACA → Anti-centromere antibody

82

Amyloid A protein, Serum (SAA)92

ACE → Angiotensin I Converting enzyme (ACE)4

ANA → Anti-nuclear antibody (ANA)80

Acetaminophen

29

Anaerobic culture181

Acetazolamide

25

Ancaron → Amiodarone

26

Anti-acethylcholine receptor antibody (anti-AChR antibody)84

Androgen receptor gene CAG repeat sequence

173

Acetone, quantitative

9

Angelman syndrome→Chromosome 15 (Congenital anomaly)125

Acetone, Urine, quantitative

9

Angelman syndrome→SNRPN gene analysis, Methylation-Specific PCR Prader-Willi syndrome Angelman syndrome

170

AChR → Anti-acethylcholine receptor antibody (anti-AChR antibody)84

Angiotensin I Converting enzyme (ACE)

4

Acid fast bacteria

185

ANP → Human atrial natriuretic peptide (HANP)

45

Acid-fast bacteria identification (mass spectrometry)

185

Anti-aquaporin 4 antibody

87

ACTH → Adrenocorticotropic hormone (ACTH)

36

Anti-ARS antibody

82

Activated partial thromboplastin time (APTT)

32

Antibody identification/antibody titer mesurement (Irregular antibody)89

ADA → Adenosine deaminase (ADA)

2

Anti-cardiolipin antibody, IgG

86

ADAMTS13 activity

33

Anti-cardiolipin antibody, IgM

86

ADAMTS13 inhibitor

33

Anti-cardiolipin β2GP I complex antibody (Anti-CL-β2 GP I antibody)

86

Adenosine deaminase (ADA)

2

Anti-centromere antibody

82

Adenovirus

54

Anti-CL-β2 GP I antibody → Anti-cardiolipin β2GP I complex antibody

86

Adenovirus DNA, qualitative

54

Anti-cyclic citrullinated peptide (CCP) antibody

82

Adiponectin, LA

45

Anti-desmoglein 1 antibody

85

Adrenocorticotropic hormone (ACTH)

36

Anti-desmoglein 3 antibody

85

Afinitor → Everolimus

26

Antidiuretic hormone (AVP)36

AFP → α-fetoprotein, quantitative46

Anti-DNA antibody, RIA

80

AICS

211

Anti-ds DNA antibody, IgG

80

AIRS

211

Anti-ds DNA antibody, IgM

80

Al → Aluminum20

Anti-GAD antibody

84

Alb → Albumin (Alb)1

Anti-galactose deficient IgG antibody

82

Albumin (Alb)1

Anti-GBM antibody (Anti-glomerular basement membrane antibody)

85

Albumin, Urine

1

Anti-glomerular basement membrane antibody (anti-GBM antibody)

85

Albumin, Urine (creatinine ratio)1

Anti-GPL core of Mycobacterium avium complex antibody (Anti-Mycobacterium antibody, qualitative)

79

Albumin-globulin ratio → A/G ratio

1

Anti-helicobacter pylori antibody, LA

76

ALD → Aldolase (ALD)

2

Anti-HEV IgA, qualitative

52

Aldolase2

Anti-histone antibody

218

Aldosterone, CLEIA

44

Anti-HLA antibody, screening

176

Aldosterone, CLEIA/Renin activity ratio

44

Anti-IA-2 antibody

84

Aldosterone, CLEIA/Renin concentration ratio

44

Anti-intrinsic factor antibody

82

Aleviatin → Phenytoin

24

Anti-islet cell antibody (ICA)218

ALK 2p23 translocation

127

Anti-Jo-1 antibody

82

Alkaline phospathase (ALP), IFCC

2

Anti-liver/kidney microsome 1 antibody → Anti-LKM-1 antibody

87

Alkaline phosphatase isoenzymes, IFCC

2

Anti-LKM-1 antibody

87

ALP → Alkaline phospathase (ALP), IFCC

2

Anti-MDA5 antibody

82

ALT (GPT)

2

Anti-melanoma differentiation associated gene 5 (MDA5) antibody

82

Aluminum (Al)20

Anti-Mi-2 antibody

82

AMA → Anti-mitochondrial antibody

82

Anti-mitochondrial antibody

82

AMH→Anti-mullerian hormone (AMH), CLEIA

42

Anti-mitochondrial M2 antibody

82

Amikacin

23

Anti-mullerian hormone (AMH), CLEIA

42

Amikamycin → Amikacin

23

Anti-MuSK antibody → Muscle-specific receptor tyrosine kinase antibody (Anti-MuSK antibody)84

Amino acid analysis, 2 types (Tyrosine/Phenylalanine) LC/MS

7

Anti-Mycobacterium antibody, qualitative→Anti-GPL core of Mycobacterium avium complex antibody (Anti-Mycobacterium antibody, qualitative)

79

Amino acid analysis, 9 types LC/MS

7

Anti-neutrophil antibody

218

Amino acid analysis, 39 types LC/MS

7

Anti-nuclear antibody (ANA)80

Amino acid analysis, 41 types

7

Anti-P/Q-type voltage-gated calcium channels antibody (Anti-P/Q VGCCs antibody)84

Amiodarone

26

Anti-p53 antibody

48

Amisalin → Procainamide

27

Anti-parietal cell antibody

82

Ammonia6

Anti-phospholipid antibody → Anti-cardiolipin antibody, IgG

86

AmoyDx Lung Cancer Multipanel for research

163

Anti-phospholipid antibody → Anti-cardiolipin antibody, IgM

86

AmoyDx Lung Cancer Multipanel IVD

162

Anti-phospholipid antibody → Anti-cardiolipin β2 GPⅠ complex antibody (Anti-CL-β2 GP I antibody)86Index(Alphabet)

32

Basic fetoprotein (BFP)

Anti-platelet antibody

87

BCA225 → Breast carcinoma associated antigen (BCA225)

46

Anti-prothrombin antibody

218

B-cell surface immunoglobulin (Sm-Ig) IgG

108

Anti-RNA polymerase Ⅲ antibody

80

B-cell surface immunoglobulin (Sm-Ig) IgA

108

Anti-RNP antibody

80

B-cell surface immunoglobulin (Sm-Ig) IgM

108

Anti-Scl-70 antibody

80

B-cell surface immunoglobulin (Sm-Ig) IgD

108

Anti-skin antibody

218

B-cell surface immunoglobulin (Sm-Ig) K

108

Anti-Sm antibody

80

B-cell surface immunoglobulin (Sm-Ig) L

108

Anti-smooth muscle antibody

82

BCL2 18q21 translocation

131

Anti-ss DNA antibody, IgG

80

BCL6 3q27 translocation

127

Anti-ss DNA antibody, IgM

80

BCR-ABL1 t(9;22) translocation

129

Anti-SS-A/Ro antibody

80

Bence Jones protein identification, Urine immunoelectrophoresis

90

Anti-SS-B/La antibody

80

Benzalin → Nitrazepam

24

Anti-streptolysin-O antibody (ASO)76

Bepricor → Bepridil

26

Antithrombin Ⅲ (AT-Ⅲ)

32

Bepridil26

Anti-thyroglobulin antibody, CLEIA84

BFP → Basic fetoprotein (BFP)

46

Anti-thyroid peroxidase antibody (Anti-TPO antibody), CLEIA84

BGP → Osteocalcin

45

Anti-TIF1-γ antibody

82

Biklin → Amikacin

23

Anti-Topoisomerase 1 Antibody → Anti-Scl-70 antibody

80

Bile acids, total

13

Anti-TPO-Ab → Anti-thyroid peroxidase antibody (Anti-TPO antibody), CLEIA

84

Bilirubin fractionation (direct, indirect)

19

Anti-transcriptional intermediary factor 1-γ (TIF1-γ) antibody

82

Bilirubin, total (T-Bil)

19

Anti-Trichosporon asahii antibody

79

BIRC3-MALT1(API2-MALT1) t(11;18) translocation

129

Anti-β2 glycoprotein Ⅰ antibody, IgG

86

Bird allergen-specific IgG antibody

79

Anti-β2 glycoprotein Ⅰ antibody, IgM

86

B-J protein → Urine immunoelectrophoresis, Bence Jones protein identification

90

Apolipoprotein A-Ⅰ

14

Bladder cancer FISH (UroVysion)

193

Apolipoprotein A-Ⅱ

14

Block preparation

196

Apolipoprotein B

14

Blood 11-OHCS

38

Apolipoprotein C-Ⅱ

14

Blood group Rh-Hr type88

Apolipoprotein C-Ⅲ

14

Blood sugar (BS) → Glucose

8

Apolipoprotein E

14

Blood type incompatibility

88

Apolipoprotein E phenotype

14

BMG → β2-microglobulin

92

Aprindine26

BNP → Human brain natriuretic peptide(BNP)45

APTT → Activated partial thromboplastin time (APTT)

32

Bone alkaline phosphatase (BAP)2

Ara h 2 → Specific IgE (Peanut-derived)

98

Bordetella antibody, EIA

76

Arbekacin

23

Bordetella antibody, IgA

76

ARC → Renin concentration (ARC), CLEIA

44

Bordetella antibody, IgM

76

ArcherMETex14 skipping, FFPE

154

Bordetella pertussis DNA

190

Ascorbic acid (Vitamin C)

16

BP180 antibody (serum anti-BP180NC16a antibody)

85

ASMA → Anti-smooth muscle antibody

82

BRAF exon15 V600E (SEQ)

151

ASO → Anti-streptolysin-O antibody (ASO)

76

BRAF V600 mutation analysis, PCR

151

Aspenon → Aprindine

26

BRAF V600E protein, IHC

206

Aspergillus antibody IgG

78

BRCA1/2 gene test

168

Aspergillus antigen

78

Breast cancer HER2 gene, FISH

202

Aspirin → Salicylates

29

Breast cancer HER2 protein, IHC, 4B5

202

AST (GOT)

2

Breast cancer HER2/neu protein, staining method

202

AT-Ⅲ → Antithrombin Ⅲ

32

Breast cancer PD-L1 protein, IHC, 22C3

202

ATLV (HTLV-I) antibody, CLEIA

70

Breast cancer PD-L1 protein, IHC, SP142

202

ATLV (HTLV-I) antibody, PA

70

Breast carcinoma associated antigen (BCA225)

46

ATLV (HTLV-I) Provirus DNA (Clonality)

70

Bromperidol

28

ATM 11q deletion

129

BS→Glucose

8

Atopy screening test (12 inhalation allergens)98

BTR → Molar ratio of total branched-chain amino acid to tyrosine (BTR)

7

Autoantibody against cancer-associated retinopathy (CAR)

223

Bufferin→ Salicylates

29

Autoantibody against myelinassociated glycoprotein (MAG)221

BUN → Urea nitrogen (UN)6

Autotaxin

94

AVP → Antidiuretic hormone (AVP)36

AZF→Y chromosome microdeletion (AZF region)

173

B
B cell percentage T cell percentage
BAP → Bone alkaline phosphatase (BAP)

page

C

46

page

C1 esterase inhibitor activity → C1 inactivator activity

91

C1 esterase inhibitor, quantitative

218

C1 inactivator activity (C1 esterase inhibitor activity)

91

108

C3 → Complement factor (C3)91

2C4 → Complement factor (C4)

91

Index

Antiplasmin (α2 plasmin inhibitor)

Index(Alphabet)

Index

Ca → Calcium (Ca)17

CD34, quantitative

105

CA → Catecholamines, total

39

CD38 multianalysis, multiple myeloma analysis

105

CA → Cold hemagglutinins

77

CD38, Lymphocyte surface marker analysis

109

CA15-346

CD41, Platelet surface marker analysis

108

CA19-946

CD42b, Platelet surface marker analysis

108

CA-3F → Catecholamine 3 fractionation

39

CD45 gating, Leukemia/lymphoma analysis (LLA)105

CA54/61

46

CD45 gating, Malignant lymphoma analysis (MLA)105

CA72-446

CD55, Erythrocyte surface marker analysis

105

CA125

46

CD56, Lymphocyte surface marker analysis

109

Cadmium

21

CD57, Lymphocyte surface marker analysis

109

Calcitonin

37

CD59, Erythrocyte surface marker analysis

105

Calcium (Ca)17

CD79B gene mutational analysis

135

Calculi analysis, ratio of contents

21

CEA → Carcinoembryonic antigen (CEA)46

Anti-cardiolipin β2GP I complex antibody (Anti-CL-β2 GP I antibody)86

Cellcept→Mycophenolic acid26cAMP → Cyclic AMP

45

Anti-centromere antibody

82

C-ANCA → Serine proteinase3 anti-neutrophil cytoplasmic antibody (PR3-ANCA)

87

Cercine → Diazepam

24

Cancer genome profile (FoundationOne)

166

Certican → Everolimus

26

Candida antibody

78

Ceruloplasmin

91

Candida mannan antigen

78

CH50 → Complement classical pathway91

CAR → Autoantibody against cancer- associated retinopathy (CAR)223

ChE → Cholinesterase (ChE)

Carbamazepine

24

Chimerism analysis, post-transplant, PCR

177

Carcinoembryonic antigen (CEA)46

Chimerism analysis, pre-transplant, donor, PCR

177

Anti-cardiolipin antibody, IgG

86Chimerism analysis, pre-transplant, recipient/donor, PCR

177

Anti-cardiolipin antibody, IgM

86

Chlamydia trachomatis

75

CARF → Anti-galactose deficient IgG antibody

82

Chlamydia trachomatis DNA

75

Carnitine fractionation

15

Chlamydia trachomatis IgA

75

CATCH22 → Chromosome 22 (22q11 deletion)

125

Chlamydia trachomatis IgG

75

Catecholamine3 fractionation

39

Chlamydophila (Chlamydia) pneumoniae IgA

75

Catecholamines, total

39

Chlamydophila (Chlamydia) pneumoniae IgG

75

C-band → Chromosome (Congenital anomaly)124

Chlamydophila (Chlamydia) pneumoniae IgM

75

CBFB inv(16) inversion, t(16;16) translocation

130

Chlamydophila (Chlamydia) psittaci, IgG

75

CBFB-MYH11 mRNA, qualitative

139

Chlamydophila (Chlamydia) psittaci, IgM

75

CBFB-MYH11 mRNA, quantitative

139

Chlamydophila psittaci (Chlamydia psittaci)

75

CCR4 protein, FCM

48

Chloride (Cl)17

CCR4 protein, IHC

207

Cholesterol ester rate

10

Cd → Cadmium

21

Cholesterol fractionation

13

CD toxin (GDH)

183

Cholesterol, total (T-Cho)

10

CD toxin B gene, qualitative

183

Cholinesterase (ChE)2

CD1a, Lymphocyte surface marker analysis

109

Chromium21

CD2, Lymphocyte surface marker analysis

109

Chromosomal structural variation analysis→MicroArray chromosomal test (Chromosomal structural variation analysis)

126

CD3, Lymphocyte surface marker analysis

109

Chromosome 1 (1p36 deletion syndrome)124

CD4, Lymphocyte surface marker analysis

109

Chromosome 4 (Wolf-Hirschhorn syndrome)124

CD4/CD8 ratio, Lymphocyte surface marker analysis

109

Chromosome 5 (Sotos syndrome)124

CD5, Lymphocyte surface marker analysis

109

Chromosome 7 (Williams syndrome)124

CD7, Lymphocyte surface marker analysis

109

Chromosome 8

128CD8, Lymphocyte surface marker analysis

109

Chromosome 12

130

CD10, Lymphocyte surface marker analysis

109

Chromosome 13

124

CD11b, Lymphocyte surface marker analysis

109

Chromosome 13 (Congenital retinoblastoma, RB1)

124

CD13, Lymphocyte surface marker analysis

109

Chromosome 15 (Angelman syndrome)125

CD14, Lymphocyte surface marker analysis

109

Chromosome 15 (Prader-Willi syndrome)125

CD16, Lymphocyte surface marker analysis

109

Chromosome 17 (Miller-Dieker syndrome)125

CD19, Lymphocyte surface marker analysis

109

Chromosome 18

125

CD20, Lymphocyte surface marker analysis

109

Chromosome 21

125

CD21, Lymphocyte surface marker analysis

109

Chromosome 22 (22q11 deletion)

125

CD22, Lymphocyte surface marker analysis

109

Chromosome analysis using spectral karyotyping (SKY) (Congenital anomaly)

124

CD25, Lymphocyte surface marker analysis

109

Chromosome analysis using spectral karyotyping (SKY) (Hematological disorder)

127

CD30, IHC

196

Chromosome C-Banding (Congenital anomaly)

124

CD30, Lymphocyte surface marker analysis

109

Chromosome G-Banding (Congenital anomaly)

127

CD33, Lymphocyte surface marker analysis

109

Chromosome High-resolution (Congenital anomaly)

124

CD34, Lymphocyte surface marker analysis

109

Chromosome Q-Banding (Congenital anomaly)124

2Index(Alphabet)

125

Coproporphyrin, Blood

19

Chromosome X (Hematological disorder)

131

Coproporphyrin, qualitative

19

Chromosome X (Steroid sulfatase [STS] gene)

125

Coproporphyrin, Urine

19

Chromosome Y (Congenital anomaly)

125

Cornea dystrophy→TACSTD2 Gene analysis (cornea dystrophy)

172

Chromosome Y (Hematological disorder)

131

Corpus luteum hormone → Progesterone

41

Chromosome Y (Sex-determining region Y [SRY])

125

Cortisol38

Chromosomes XY (Short stature homeobox [SHOX])

125

Cortisol, Urine

38

Cibenol → Cibenzoline

27

Coxsackie virus Group A, type 2

62

Cibenzoline

27

Coxsackie virus Group A, type 3

62

Cibenzoline succinate

27

Coxsackie virus Group A, type 462

c-kit mutation analysis (GIST)

156

Coxsackie virus Group A, type 5

62

CK-MB (CPK-MB), CLIA

1

Coxsackie virus Group A, type 6

62

CK-MB (CPK-MB), Immunological inhibition-Ultraviolet absorption spectrophotometry (UV)1

Coxsackie virus Group A, type 762

CKS1B 1q21 amplification

127

Coxsackie virus Group A, type 962

CL → Anti-cardiolipin antibody, IgG

86

Coxsackie virus Group A, type 10

62

CL → Anti-cardiolipin antibody, IgM

86

Coxsackie virus Group A, type 16

62

Cl → Chloride (Cl)17

Coxsackie virus Group B, type 1

63

Clobazam24

Coxsackie virus Group B, type 2

63

Clonazepam

24

Coxsackie virus Group B, type 3

63

CMV (Cytomegalovirus), specific CTL assay (HLA-A*0201)

123

Coxsackie virus Group B, type 463

CMV (Cytomegalovirus), specific CTL assay (HLA-A*2402)

123

Coxsackie virus Group B, type 563

CMV → Cytomegalovirus

58

Coxsackie virus Group B, type 663

CMV → Cytomegalovirus IgG

58

Cp → Ceruloplasmin

91

CMV → Cytomegalovirus IgM

58

C-PAC5 allergens → Specific IgE98

CMV → Cytomegalovirus Nucleic acid detection (newborn urine)

58

C-PAC16 allergens → Specific IgE98

CMV → Cytomegalovirus nucleic acid quantitative

58

C-peptide (CPR)43

CMV DNA → Cytomegalovirus DNA, qualitative

58

CPK → Creatine kinase1

CMV pp65 antigen (C7-HRP) → Cytomegalovirus pp65 antigen (C7-HRP)

58

CPK-MB (CK-MB), CLIA

1

CMV pp65 antigen (C10, C11) → Cytomegalovirus pp65 antigen (C10, C11)58

CPK-MB (CK-MB), Immunological inhibition-Ultraviolet absorption spectrophotometry (UV)1

Coagulation factor activity test Factor Ⅱ (F2)33

CPR → C-peptide(CPR)

43

Coagulation factor activity test Factor Ⅴ (F5)33

Cr → Chromium

21

Coagulation factor activity test Factor Ⅶ (F7)33

Cr → Creatinine

6

Coagulation factor activity test Factor Ⅷ (F8)33

C-reactive protein (CRP), quantitative

92

Coagulation factor activity test Factor Ⅸ (F9)33

Creatine

6

Coagulation factor activity test Factor Ⅹ (F10)33

Creatine kinase (CK) isoenzymes

1

Coagulation factor activity test Factor Ⅺ (F11)33

Creatine kinase (CPK)1

Coagulation factor activity test Factor Ⅻ (F12)33

Creatine phosphatase (CPK) isoenzymes

1

Coagulation factor activity test Factor  (F13)33

Creatine phosphatase → Creatine kinase (CK)1

Coagulation inhibitor identification Factor Ⅷ

33

Creatinine

Coagulation inhibitor identification Factor Ⅸ

33

Crossmatch test → Flow cytometry crossmatch, lymphocyte crossmatch test

176

Cochlin-tomoprotein (CTP)

96

CRP → C-reactive protein (CRP), quantitative

92

Cold hemagglutinins

77

Cryoglobulin, qualitative

90

Collagen type Ⅰ cross-linked N-telopeptide (NTx)93

Cryptococcus antibody

78

Collagen type Ⅰ cross-linked N-telopeptide (NTx), osteoporosis

93

Cryptococcus neoformans antigen

78

Collagen type Ⅰ, C-terminal telopeptide (ⅠCTP)

93

CSF1R 5q deletion

128

Collagen type Ⅳ

94

CSLEX → Sialyl Lewisx antigen (CSLEX)

46

Collagen type Ⅳ, Urine

94

CT → Calcitonin

37

Collagen type Ⅳ/7S, CLEIA

94

CTP→Cochlin-tomoprotein (CTP)

96

Colorectal cancer HER2 gene, FISH

202

Cu → Copper (Cu)18

Colorectal cancer HER2 protein, IHC

202

Culture and identification (blood, puncture fluid)

181

Common bacteria

181

Culture and identification (digestive organs)

181

Complement C1q

91

Culture and identification (oral cavity, airway, respiratory organs )181

Complement classical pathway

91

Culture and identification (others)

181

Complement factor (C3)91

Culture and identification (urinary, reproductive organs)

181

Complement factor (C4)91

Cyclic AMP

45

Complete blood count (CBC)31

Cyclosporine

26

Congenital long QT syndrome gene analysis

173

Anti-cyclic citrullinated peptide (CCP) antibody

82

Congenital retinoblastoma, RB1→Chromosome 13 (Congenital anomaly)124

CYFRA → Cytokeratin fragment 19

47

Coombs test (direct, indirect)

89

Cystatin C

Copper (Cu)18

Cytodiagnosis (Gynecologic LBC)

6

6
193

Index

Chromosome X (Congenital anomaly)Index(Alphabet)

Index

Cytodiagnosis (Gynecologic LBC, Bethesda system)

193

Anti-ds DNA antibody, IgG

80

Cytodiagnosis (Gynecology)

193

Anti-ds DNA antibody, IgM

80

Cytodiagnosis (Gynecology, Bethesda system)

193

DUPAN-2

46

Cytodiagnosis Sputum cell concentration (ABC classification)

193

Dystrophin DNA

172

Cytodiagnosis Sputum cell concentration (Class determination)

193

Cytokeratin fragment 19 (CYFRA)

47

E

page

Cytomegalovirus

58

E Keppra → Levetiracetam

25

Cytomegalovirus (CMV), specific CTL assay (HLA-A*0201)

123

E2 (IVF)

41

Cytomegalovirus (CMV), specific CTL assay (HLA-A*2402)

123

E2 → Estradiol

41

Cytomegalovirus DNA, qualitative

58

Echo → Esterified cholesterol (Echo)

10

Cytomegalovirus IgG

58

ECHO virus type 1

64

Cytomegalovirus IgM

58

ECHO virus type 3

64

Cytomegalovirus Nucleic acid detection (newborn urine)

58

ECHO virus type 464

Cytomegalovirus nucleic acid quantitative

58

ECHO virus type 564

Cytomegalovirus pp65 antigen (C7-HRP)

58

ECHO virus type 664

Cytomegalovirus pp65 antigen (C10, C11)58

ECHO virus type 7

64

ECHO virus type 964

ECHO virus type 11

64

D

page

D13S319 13q deletion

130

ECHO virus type 1264

D7S486 7q deletion/Chromosome 7 monosomy

128

ECHO virus type 13

65

DA → Dopamine, total

39

ECHO virus type 14

65

D-dimer

32

ECHO virus type 16

65

Dehydroepiandrosterone sulfate (DHEA-S)

38

ECHO virus type 17

65

DEK-NUP214 mRNA, qualitative

143

ECHO virus type 18

65

DEK-NUP214 mRNA, quantitative

143

ECHO virus type 19

65

Dengue virus Nonstructural Protein 1 antigen

72

ECHO virus type 21

65

Deoxypyridinoline

94

ECHO virus (Parechovirus type 1) type 22

65

Deoxypyridinoline (DPD), osteoporosis

94

ECHO virus type 24

65

Depakene → Valproate

25

ECHO virus type 25

65

Anti-desmoglein 1 antibody

85

ECHO virus type 30

65

Anti-desmoglein 3 antibody

85

EGFR mutation analysis v2.0

152

Detection of Trichomonas vaginalis (TV) and Mycoplasma genitalium (MG) DNA

191

EGFR mutation analysis v2.0 (plasma)

152

DHEA-S → Dehydroepiandrosterone sulfate (DHEA-S)

38

EGR1 5q deletion

128

Diacomit→Stiripentol

25

EL-1 → Elastase 1

3

Diamox → Acetazolamide

25

Elastase 1

3

Diapax → Diazepam

24

Eltacin→Gentamicin

23

Diazepam

24

EML4-ALK fusion gene, qualitative

154

Digestion state

178

Endotoxin in dialysis fluid Others

76

Digosin → Digoxin

26

Endotoxin in dialysis fluid Preparation solution

76

Digoxin26

Endotoxin in dialysis fluid Solution A

76

Diphenylhydantoin → Phenytoin

24

Endotoxin in dialysis fluid Solution B

76

Diphtheria toxin antibody

218

Endotoxin in dialysis fluid Solution RO

76

Direct coombs test

89

Endotoxin, quantitative76

Disopyramide

27

Entamoeba histolytica DNA qualitative

190

DLST → Drug-induced lymphocyte stimulation test (DLST)

107

Enterotoxin typing

183

Anti-DNA antibody, RIA

80

Enterovirus type 70

62

DNA methylation analysis of miR34b/c

217

Enterovirus type 71

62

DNA methylation analysis of PCDHB

217

Environmental tests (stamping method)183

DNA typing HLA-A

175

Environmental tests (wiping method)183

DNA typing HLA-B

175

Enzyme antibody staining [Formalin fixed tissues]

196

DNA typing HLA-C

175

Eosinophil granulocyte count30

DNA typing HLA-DPB1

175

Epileo petit mal → Ethosuximide

24

DNA typing HLA-DQB1

175

EPO → Erythropoietin

45

DNA typing HLA-DRB1

175

Epstein-Barr virus DNA (Clonality)

59

Dopamine, total

39

Epstein-Barr virus DNA, quantitative59

DPD (Deoxypyridinoline), osteoporosis

94

Epstein-Barr virus, anti-EA IgG, EIA

60

DPD → Deoxypyridinoline

94

Epstein-Barr virus, anti-EA-DR IgA, FA

60

Drug metabolizing enzyme cytochrome P450 CYP2C19 gene polymorphism analysis

174

Epstein-Barr virus, anti-EA-DR IgG, FA

60

Drug susceptibility test for acid-fast bacteria

185

Epstein-Barr virus, anti-EBNA IgG, EIA

60

Drug-induced lymphocyte stimulation test (DLST)107

Epstein-Barr virus, anti-EBNA, FA

60

Index(Alphabet)

60

Fibrinogen (FIB)

Epstein-Barr virus, anti-VCA IgG, EIA

60

Fibroblast growth factor 23 (FGF23), CLEIA

45

Epstein-Barr virus, anti-VCA IgG, FA

60

FIP1L1-PDGFRA 4q deletion (4q12 deletion)

128

Epstein-Barr virus, anti-VCA IgM, EIA

60

Flecainide

28

Epstein-Barr virus, anti-VCA IgM, FA

60

Flow cytometry crossmatch, lymphocyte crossmatch test

176

ER → Estrogen receptor, IHC

202

FLT3 mutational analysis ITD/TKD

133

ER/PgR → Estrogen receptor/progesterone receptor, IHC

202

FLT3/ITD mutation analysis

133

Erythrocyte surface marker analysis, CD55

105

Folic acid

16

Erythrocyte surface marker analysis, CD59

105

Follicle stimulating hormone (FSH)36

Erythropoietin

45

FoundationOne CDx Cancer genome profile

166

Escherichia coli toxin-related test

183

FoundationOne Liquid CDx Cancer genome profile

166

Esophageal cancer PD-L1 protein, IHC, 22C3

202

Fragile X chromosome (Fragile X syndrome)

124

Esophageal cancer PD-L1 protein, IHC, 28-8

202Free cholesterol (F-Cho)

10

Esterified cholesterol (Echo)

10

Free fatty acid (NEFA)

10

Estradiol (E2)41Free HCG-β (HCG-β subunit)

42

Estradiol (E2) (IVF)

41

Free T3 → Free triiodothyronine (Free T3) , CLEIA

37

Estrogen receptor, IHC

202

Free T4 → Free thyroxine (Free T4), CLEIA

37

Estrogen receptor/progesterone receptor, IHC

202

Free thyroxine (Free T4) , CLEIA

37

Ethanol

21

Free triiodothyronine (Free T3) , CLEIA

37

Ethosuximide

24

FSH → Follicle stimulating hormone (FSH)36

ETV6-RUNX1 mRNA, qualitative

141

FT3 → Free triiodothyronine (Free T3) , CLEIA37

ETV6-RUNX1 mRNA, quantitative

141

FT4 → Free thyroxine (Free T4), CLEIA37

ETV6-RUNX1(TEL-AML1) t(12;21) translocation

130

FTA-ABS77

Everolimus

26

Fukuyama-type congenital muscular dystrophy DNA insertion

172

EWSR1 22q12 translocation

132

Fycompa → Perampanel

25

Excegran → Zonisamide

25

EZH2 gene mutational analysis

136

F

page

G

32

page

Anti-glomerular basement membrane antibody (anti-GBM antibody)85

GA → Glycoalbumin

8

F1+2 → Prothrombin fragment F1+2

32

GABA → γ-aminobutyric acid (GABA)

8

Factor Ⅱ (Coagulation factor activity test)

33

Gabapen tablets→Gabapentin

25

Factor Ⅴ (Coagulation factor activity test)

33

Gabapentin

25

Factor Ⅶ (Coagulation factor activity test)

33

Anti-GAD antibody

84

Factor Ⅷ (Coagulation factor activity test)

33

Anti-galactose deficient IgG antibody

82

Factor Ⅷ (F8), Chromogenic Substrate method

33

Gastric cancer HER2 gene, FISH

202

Factor Ⅸ (Coagulation factor activity test)

33

Gastric cancer HER2 protein, IHC

202

Factor Ⅸ (F9), Chromogenic Substrate method

33

Gastric cancer PD-L1 protein, IHC, 28-8

202

Factor Ⅹ (Coagulation factor activity test)

33

Gastric cancer risk screening (ABC classification), eradicated, LA

Factor Ⅺ (Coagulation factor activity test)

33

Gastric cancer risk screening (ABC classification), LA

Factor Ⅻ (Coagulation factor activity test)

33

Gastrin

216

Factor  (Coagulation factor activity test)

33

GATA2-MECOM inv(3) inversion, t(3;3) translocation

127

Factor Ⅷ (Coagulation inhibitor identification)

33

G-band → Chromosome (Congenital anomaly)

124

Factor Ⅸ (Coagulation inhibitor identification)

33

G-band → Chromosome (Hematological disorder)

127

Familial amyloidosis→TTR gene analysis (Familial amyloidosis)

171

G-band → Fragile X chromosome (Congenital anomaly)

124

Familial Mediterranean fever→MEFV gene analysis (Familial Mediterranean fever)173

GBM antibody → Antiglomerular basement membrane antibody (anti-GBM antibody)

85

Fatty acid fractionation (4)12

GDLD→TACSTD2 Gene analysis (cornea dystrophy)

172

Fatty acid fractionation (24)12

Gelatinous drop-like cornea dystrophy ー→TACSTD2 Gene analysis (cornea dystrophy)

172

Fbg → Fibrinogen (FIB)

32

General cytodiagnosis

193

F-Cho → Free cholesterol (F-cho)10

Gentacin→Gentamicin

23

FDP, quantitative (plasma)

32

Gentamicin

23

FDP, quantitative (random urine)

32

GH → Growth hormone (GH)36

Fe → Iron (Fe)18

Glivec→Imatinib

29

Fecal calprotectin, ELISA83

GLU → Glucose

8

Fecal calprotectin, FEIA

83

Glucose8

Fecal examination for medical checkup

184

Glycoalbumin

8

Fecal Helicobacter pylori antigen

76

GOT → AST (GOT)

2Ferritin93

GPT → ALT (GPT)2

FGF23 → Fibroblast growth factor 23 (FGF23), CLEIA

45

Graceptor → Tacrolimus

26

FGFR1 8p11.2 translocation

129

Granulocyte Antibody → Anti-neutrophil antibody

218

Fibrin monomer complex, quantitative

32

Granulocyte elastase in cervical mucus

5
5

3

Index

Epstein-Barr virus, anti-VCA IgA, FA

Index(Alphabet)

Index

Growth hormone (GH)36

HHV-6 → Human herpesvirus, type 6 DNA quantitative

61

GST → Gastrin216

HHV-6 → Human herpesvirus, type 6 DNA, qualitative

61

GU → Guanase2

HHV-6 → Human herpesvirus, type 6 DNA, quantitative

61

Guanase2

HHV-7 DNA → Human herpesvirus, type7 DNA, qualitative

61

H

page

HIAA → 5-Hydroxyindoleacetic Acid (5-HIAA)

40

High molecular weight adiponectin, CLEIA

217

HA → Hyaluronic acid (pleural fluid)

8

High sensitivity PNH testing105

HA → Hyaluronic acid (serum)

8High sensitivity tumor necrosis factor alpha (TNF-α)215

HA antibody

51

High-resolution banding → Chromosome (Congenital anomaly)124

HA antibody-IgM

51

Hippuric acid, Urine

20

Habekacin → Arbekacin

23

Anti-histone antibody

218

Halomonth → Haloperidol

28

Histopathological test (Bone marrow biopsy)

196

Haloperidol

28

Histopathological test (General pathology)

196

Halosten → Haloperidol

28

Histopathological test (Kidney biopsy)

196

HANP → Human atrial natriuretic peptide (HANP)

45

Histopathological test (Liver biopsy)

196

Haptoglobin

91

HIT antibody (Platelet factor 4-heparin complex antibody)87

HBc antibody

50

HIV, antigen/antibody

71

HBc antibody (IgG)

50

HIV-1 RNA quantitative71

HBc antibody-IgM

50

HIV-1/2 specific antibodies

71

HBcrAg → Hepatitis B virus core antigen (HBcrAg)

50

Anti-HLA antibody, screening

176

HBe antibody

50

HLA DNA typing, NGS-SBT method

175

HBe antigen

50

HLA-A, B, serological typing

175

HBs antibody

49

HLA-A, DNA typing

175

HBs antibody, CLEIA49

HLA-B, DNA typing

175

HBs antigen (HQ)49

HLA-C, DNA typing

175

HBV DNA quantitative, IU

49

HLA-DPB1, DNA typing

175

HBV genotype

49

HLA-DQB1, DNA typing

175

HCG → Human chorionic gonadotropin (HCG)42

HLA-DR, Lymphocyte surface marker automate analysis

109

HCG-β subunit →Free HCG-β (HCG-β subunit)

42

HLA-DR, serological typing

175

HCV antibody, the third generation for screening

51

HLA-DRB1, DNA typing

175

HCV Grouping for interferon therapy

51

Homocystein, total

8

HCV RNA core genotype

51

Homovanillic Acid → HVA

40

HCV RNA quantitative

52

Horizon → Diazepam

24

HDL 2,3-cholesterol

10

Hp → Haptoglobin

91

HDL-cholesterol

10

HPV DNA → Human papillomavirus DNA (genotypes 16, 18, and other highrisk groups)

53

HE4 → Human epididymis protein 4 (HE4)46

HPV DNA → Human papillomavirus DNA (high-risk group)

53

Head and neck cancer PD-L1 protein, IHC, 22C3207

HPV DNA → Human papillomavirus DNA (high-risk group) (LBC)

53

Head and neck cancer PD-L1 protein, IHC, 28-8

207

HPV DNA → Human papillomavirus DNA (low-risk group)

53

Anti-helicobacter pylori antibody, LA

76

HSV → Herpes simplex virus

55

Helicobacter pylori determination

196

HSV → Herpes simplex virus IgG

55

Hemoglobin A1c (HbA1c) (NGSP)

8

HSV → Herpes simplex virus IgM

55

Hemoglobin and transferrin in feces

178

HSV → Herpes simplex virus type 1

56

Hemoglobin in feces, qualitative

178

HSV → Herpes simplex virus type 256

Hemoglobin in feces, quantitative

178

HSV → Herpes simplex virus, type 1/2-IgG

56

Heparin

29

HSV DNA → Herpes simplex virus DNA, qualitative

56

Hepatitis B virus core antigen (HBcrAg)

50

HSV DNA → Herpes simplex virus DNA, quantitative

56

Hepatitis C virus core antigen

52

HSV specific antigen → Herpes simplex virus specific antigen

55

Hepatocyte growth factor (HGF)

45

HTLV-1 antibody

70

HER2 protein

48

HTLV-1 nucleic acid detection, qualitative70

Herpes simplex virus

55

HTLV-1 Provirus DNA, qualitative70

Herpes simplex virus DNA, qualitative

56

HTLV-I antibody, CLEIA

70

Herpes simplex virus DNA, quantitative

56

HTLV-I antibody, PA

70

Herpes simplex virus IgG

55

HTLV-I Provirus DNA (Clonality)

70

Herpes simplex virus IgM

55

HTT gene CAG repeat sequence173

Herpes simplex virus specific antigen

55

Hu autoantibody

223

Herpes simplex virus type 1

56

Human atrial natriuretic peptide (HANP)

45

Herpes simplex virus type 2

56

Human brain natriuretic peptide (BNP)

45

Herpes simplex virus, type 1/2-IgG

56

Human chorionic gonadotropin (HCG)42

H-FABP → Human heart type fatty acid-binding protein (H-FABP)

92

Human chorionic gonadotropin beta-subunit (HCG-β subunit)

42

HGF → Hepatocyte growth factor (HGF)

45

Human epididymis protein 4 (HE4)46

Index(Alphabet)

92

Immune complex (Monoclonal RF)

87

Human herpesvirus, type 6 DNA, qualitative

61

Immunoelectrophoresis, identification by anti-total human serum

90

Human herpesvirus, type 6 DNA, quantitative

61

Immunoelectrophoresis, specific antiserum

90

Human herpesvirus, type 7 DNA, qualitative

61

Immunoelectrophoresis, specific antiserum (DIRA)

90

Human interferon γ, EIA

97

Immunoglobulin free light chain κ/λ90

Human leukocyte antigen → HLA

175

Immunoglobulin G (IgG), subclass fractionation (TIA)

90

Human oncofetal fibronectin

93

Immunoglobulin H-chain Cμ rearrangement

150

Human papillomavirus (HPV) genotyping

53

Immunoglobulin H-chain JH rearrangement

150

Human papillomavirus DNA (genotypes 16, 18, and other highrisk groups)

53

Immunoglobulin L-chain Cκ rearrangement

150

Human papillomavirus DNA (high-risk group)

53

Immunoglobulin L-chain Cλ rearrangement

150

Human papillomavirus DNA (high-risk group) (LBC)

53

Immunoglobulin L-chain Jκ rearrangement

150

Human papillomavirus DNA (low-risk group)

53

Impromen → Bromperidol

28

Human parvovirus B19 DNA, qualitative

52

Inderal → Propranolol

27

Human parvovirus B19 IgG

52

Indirect coombs test89

Human parvovirus B19 IgM

52

Influenza virus type A

67

HVA

40

Influenza virus type A (H1N1)(H3N2)

67

Hyaluronic acid (pleural fluid)

8

Influenza virus type B, CF

67

Hyaluronic acid (serum)

8

Influenza virus type B, HI

67

Hydantol → Phenytoin

24

Inorganic phosphorus (P)17

Hydroxyproline, total

8

Inovelon→Rufinamide

25

Hyserenin → Valproate

25

Insulin

43

Insulin antibody

84

Insulin-like growth factor 1→IGF-1 (Somatomedin C)

36

I

page

Anti-IA-2 antibody

84

Intact-PTH → Parathyroid hormone (PTH), intact

37

ICA → Anti-islet cell antibody (ICA)

218

Integrated analysis of malignant lymphoma, ML-NET

210

IC-mRF → Immune complex (Monoclonal RF)

87

Interleukin-1β (IL-1β)

97

IDH1/2 gene analysis (Glioma)

156

Interleukin-4 (IL-4) (High sensitivity)

97

IEP → Immunoelectrophoresis

90

Interleukin-6 (IL-6)

97

IFNγ → Human interferon γ, EIA

97Interleukin-8 (IL-8)

97

IFN-γ×IL-4/CD4 (Th1/Th2)

108

Interleukin-10 (IL-10)

97

IgA → B-cell surface immunoglobulin (Sm-Ig) IgA

108

Anti-intrinsic factor antibody

82

IgA → Immunoglobulin A

90

Inulin, quantitative

21

IgA anti-HEV, qualitative

52

Ionized calcium

17

IgD → B-cell surface immunoglobulin (Sm-Ig) IgD

108

IRI → Insulin

43

IgE (atopy screening test) → Atopy screening test (12 inhalation allergens)

98

Iron (Fe)18

IgE (C-PAC) → Specific IgE (C-PAC 5 allergens)

98

Irregular antibody (Antibody identification/antibody titer mesurement)

89

IgE (C-PAC) → Specific IgE (C-PAC 16 allergens)98

IRT → Trypsin

IgE (non-specific IgE, specific IgE)

98

Anti-islet cell antibody (ICA)218

IGF-1 (Somatomedin C)

36

Isolation and culture of acid-fast bacteria, liquid medium

185

IgG → B-cell surface immunoglobulin (Sm-Ig) IgG

108

Isolation and culture of acid-fast bacteria, Ogawa medium

185

IgG → Immunoglobulin G

90

IVF-Estradiol (E2)

41

IgG2

90

IVF-Progesterone

41

IgG4

90

IgG-FcR+/T cell percentage

108

IGH-BCL2 t(14;18) translocation

130

JAK2V617F mutational analysis

134

IGH-CCND1(IGH-BCL1) t(11;14) translocation

129

Japanese encephalitis virus

66

IGH-FGFR3 t(4;14) translocation

128

Japanese encephalitis virus, JaGAr strains

66

IGH-MAF t(14;16) translocation

130

Anti-Jo-1 antibody

82

IGH-MYC t(8;14) translocation

128

IgM → B-cell surface immunoglobulin (Sm-Ig) IgM

108

IgM → Immunoglobulin M

90

K → B-cell surface immunoglobulin (Sm-Ig) K

108

IgM-HA antibody

51

K → Potassium (K)17

IgM-HBc antibody

50

Kafier → Disopyramide

27

IL-1β → Interleukin-1β (IL-1β)

97

Ketone bodies fractionation

IL-4 → Interleukin-4 (High sensitivity)

97

KIT sequence analysis (leukemia)

IL-6 → Interleukin-6 (IL-6)

97

KL-6

95

IL-8 → Interleukin 8 (IL-8)

97

KMT2A (MLL) 11q23.3 translocation129

IL-10 → Interleukin 10 (IL-10)

97

KMT2A-AFDN mRNA, qualitative

142

IL28B SNPs analysis

174

KMT2A-AFDN mRNA, quantitative

142

Imatinib

29

KMT2A-AFF1 mRNA, qualitative

141

J

K

3

page

page

9
133

Index

Human heart type fatty acid-binding protein (H-FABP)

Index(Alphabet)

Index

KMT2A-AFF1 mRNA, quantitative

141

Lung cancer compact panel CDx

164

KMT2A-MLLT1 mRNA, qualitative

142

Lung cancer compact panel for research

164

KMT2A-MLLT1 mRNA, quantitative

142

Lung cancer PD-L1 protein, IHC, 22C3

207

KMT2A-MLLT3 mRNA, qualitative

142

Lung cancer PD-L1 protein, IHC, 28-8

207

KMT2A-MLLT3 mRNA, quantitative

142

Lung cancer PD-L1 protein, IHC, SP142

207

KRAS G12C mutational analysis

155

Lung cancer PD-L1 protein, IHC, SP263

207

Lupus-anticoagulant, APTT clotting time

85

Lupus-anticoagulant, Diluted Russell's viper venom time test

85
85

L

page

L → B-cell surface immunoglobulin (Sm-Ig) L

108

Lupus-anticoagulant, Phospholipid neutralization method

L fatty acid binding protein (L-FABP), CLEIA

93

Luteinizing hormone (LH)36

LAC → Lupus-anticoagulant, APTT clotting time85

Lymphocyte blastoid transformation by Con-A

107

LAC → Lupus-anticoagulant, Diluted Russell's viper venom time test

85

Lymphocyte blastoid transformation by PHA

107

LAC → Lupus-anticoagulant, Phospholipid neutralization method

85

Lymphocyte surface marker analysis by two-color analysis

108

Lacosamide

25

Lymphocyte surface marker automated analysis by monoclonal antibody

108

Lactate dehydrogenase → LD (LDH), IFCC

2

Lysozyme

Lactate dehydrogenase isoenzymes → LD (LDH) isoenzymes

2

Lactic acid9

Lamictal → Lamotrigine

25

M. tuberculosis complex antigen

Lamotrigine

25

M2BPGi → Mac-2 binding protein glycosylated isomers (M2BPGi)

94

Landsen → Clonazepam

24

MAG → Autoantibody against myelin-associated glycoprotein (MAG)221

LAP → Leucine aminopeptidase (LAP)

2

Magnesium (Mg)

17

LD (LDH), IFCC

2

Major BCR-ABL1 mRNA(％ )137

LD (LDH) isoenzymes

2

Major BCR-ABL1 mRNA(IS)137

LDH → LD(LDH), IFCC

2

Major BCR-ABL1 mRNA, qualitative137

LDH (LD) isoenzymes

2

Major BCR-ABL1 mRNA, quantitative137

LDL-cholesterol

10

Malignant lymphoma ALK protein, IHC

196

L-dopa39

Malignant lymphoma analysis (MLA), CD45 gating, test for hematopoietic malignant tumor cell

105

Lead (Pb)

21

Malignant lymphoma analysis, 7AAD analysis, test for hematopoietic malignant tumor cells

105

Legionella DNA, qualitative

190

MALT1 18q21 translocation

130

Leptin216

Mandelate ethylbenzene, Urine

20

Leptin, ELISA

45

Manganese

21

Leucine aminopeptidase (LAP)

2

MAST 36 allergens → Specific IgE

98

Leucine-rich alpha 2 glycoprotein (LRG)

83

MAST 48mix → Specific IgE

98

Leukemia/lymphoma analysis (LLA), CD45 gating

105

Mb → Myoglobin

92

Levetiracetam

25

MBP → Myelin basic protein (MBP)

85

Lexin → Carbamazepine

24Anti-MDA5 antibody

82

LH → Luteinizing hormone (LH)36

Measles virus

68

LHON mtDNA evaluation

221

Measles virus IgG

68

Lidocaine27

Measles virus IgM

68

Limas → Lithium

28

MECP2 (exons 3 and 4) mutation analysis

171

Linton → Haloperidol

28

MEFV gene analysis (Familial Mediterranean fever)173

Lipase3

Anti-melanoma differentiation associated gene 5 (MDA5) antibody

82

Lipoprotein (a)14Melanoma PD-L1 protein, IHC, 28-8

207

Lipoprotein fractionation, Agalose gel electrophoresis

13

MELAS mtDNA evaluation

222

Lipoprotein lipase (LPL)14

MERRF mtDNA evaluation

222

Lithium

28

Metanephrine/Normetanephrine, fractionation

39

Litiomal → Lithium

28

METex14 skipping→ArcherMETex14 skipping, FFPE

154

Anti-liver/kidney microsome 1 antibody → Anti-LKM-1 antibody

87

Methotrexate

29

Anti-LKM-1 antibody

87

Methylhippuric acid, Urine

20

LLA → Leukemia/lymphoma analysis (LLA), CD45 gating, test for hematopoietic malignant tumor cells

105

Mexilethine27

LP(a) → Lipoprotein (a)14Mexitil → Mexilethine

27

LPL → Lipoprotein lipase (LPL)

14

Mg → Magnesium (Mg)17

LRG → Leucine-rich alpha 2 glycoprotein (LRG)83

MHA → Methylhippuric acid, Urine

20

LST → Drug-induced lymphocyte stimulation test (DLST)

107

MHPG → 3-Methoxy-4-Hydroxyphenylglycol

40

Luinesin→Gentamicin

23

Anti-Mi-2 antibody

82

Luminal → Phenobarbital

24

micro BCR-ABL1 mRNA, qualitative

138

Lunapron → Bromperidol

28

MicroArray chromosomal test (Chromosomal structural variation analysis)

126

Lung cancer ALK gene, FISH

207

Microsatellite instability (MSI) test

157

Lung cancer ALK protein, Highly sensitive IHC

207

Microsatellite instability (MSI) test (lynch syndrome)

170

Lung cancer ALK protein, IHC, D5F3

207

Microscopic examination of smears

181

M

4
page
185

Index(Alphabet)125

NAG → N-acetyl glucosaminidase (NAG)

4

Minoale → Trimethadione

25

Napa → Acetaminophen

29

minor BCR-ABL1 mRNA(％)

138

NARP mtDNA evaluation

222

minor BCR-ABL1 mRNA, qualitative

138

Nasal eosinophils

31

minor BCR-ABL1 mRNA, quantitative

138

Natural killer cell activity

108

Mismatch repair protein→MMR protein, IHC

206

NCC Oncopanel System

165

Mismatch repair protein→MMR protein, IHC (Lynch syndrome)

206

NCC-ST-439

46

Mitochondria DNA evaluation

221､222

NEFA (Free fatty acid)Anti-mitochondrial antibody

1082

Neisseria gonorrhoeae DNA

191

Anti-mitochondrial M2 antibody

82

Nelbon → Nitrazepam

24

Mixed lymphocyte culture (MLC)107

Neoperidol → Haloperidol

28

MLA → Malignant lymphoma analysis (MLA), CD45 gating, test for hematopoietic malignant tumor cell

105

Neopterin

21

MLC → Mixed lymphocyte culture

107

Neoral → Cyclosporine

26

MLC I → Ventricle myosin light chain I

92

Neuron specific enolase (NSE)48

MLH1→MMR protein, IHC

206

Anti-neutrophil antibody

218

MLH1→MMR protein, IHC (Lynch syndrome)206

NH3 → Ammonia

6ML-NET → Integrated analysis of malignant lymphoma, ML-NET

210

Niacin (Nicotinic acid)16

4

Nicotinic acid (niacin)

16

MMP-3 → Matrix metalloproteinase 3 (MMP-3)
MMR protein, IHC

206

Nitrazepam

24

MMR protein, IHC (Lynch syndrome)

206

Nitrite/Nitrate ion

216

Mn → Manganese21

N-methylformamide, Urine

20

Molar ratio of total branchedchain amino acid to tyrosine (BTR)

7

Non-specific IgE → IgE

98

Monoclonal RF (Immune complex)

87

Norovirus antigen

72

MPN gene mutational analysis

134

Norovirus RNA, qualitative

72

MPO-ANCA → Myeloperoxidase anti-neutrophil cytoplasmic antibody

87

Norpace → Disopyramide

27

mRF → Immune complex (Monoclonal RF)

87

NPM1 mutational analysis

133

MRSA screening

184

NSE → Neuron specific enolase (NSE)48

MSH2→MMR protein, IHC

206

N-terminal fragment of human brain natriuretic peptide precursor (NT-proBNP)

45

MSH2→MMR protein, IHC (Lynch syndrome)206

NT-proBNP → N-terminal fragment of human brain natriuretic peptide precursor (NT-proBNP)

45

MSH6→MMR protein, IHC

206

NTx → Collagen type I cross-linked N-telopeptide (NTx)93

MSH6→MMR protein, IHC (Lynch syndrome)206

NTx → Collagen type I cross-linked N-telopeptide (NTx), osteoporosis

93

MSI test → Microsatellite instability (MSI) test

157

Anti-nuclear antibody (ANA)80

MSI test → Microsatellite instability (MSI) test (lynch syndrome)

170

Nuclear matrix protein 22, Urine (NMP22)48

Anti-mullerian hormone (AMH), CLEIA

42

Nucleic acid identification of M. tuberculosis complex, TRC

185

Multiple myeloma analysis CD38 multianalysis, test for hematopoietic malignant tumor cells

105

Nucleic acid identification of MAC, TRC

185

Multiple myeloma multiparameter flow cytometry (8-color)105

NUDT15 gene codon 139 polymorphism analysis

174

Mumps virus

69

NUP98 11p15 translocation

129

Mumps virus IgG

69

NUP98-HOXA9 mRNA, quantitative

143

Mumps virus IgM

69

Muscle-specific receptor tyrosine kinase antibody (anti-MuSK antibody)84

Mutation analysis in the ABL1 region, major BCR-ABL1

137

O-157 screening

Mutation analysis in the ABL1 region, minor BCR-ABL1

138

Oligoclonal band

90

My Nightingale

214

Oncomine Dx Target Test Multi-CDx

158

MYC 8q24 translocation

128

Oncomine Dx Target Test Multi-for research 46 genes analysis

160

myChoice diagnostic system

167

OncomineDxTT Multi-CDx (thyroid cancer)

159

MYCN 2p24 amplification

132

OncomineDxTT Multi-for research (thyroid cancer)

161

Mycophenolic acid26

Oncopanel System → NCC Oncopanel System

165

Mycoplasma pneumoniae

77

OncotypeDX DCIS, Colon

219

Mycoplasma pneumoniae DNA

190

Organic acid-screening

9

MYD88 gene mutational analysis

135

Osmotic pressure, random urine

17

Myelin basic protein (MBP)85

Osmotic pressure, serum

17

Myeloperoxidaseantineutrophil cytoplasmic antibody (MPO-ANCA)

87

Osteocalcin

45

Myocardial troponin T

92

Oxalic acid, Urine

9

Myoglobin

92

Oxidized LDL (MDA-LDL)

12

Myoglobin, Urine, CLEIA

92

Mystan → Clobazam

24

N

page

O

P

page
184

page

P → Inorganic phosphorus(P)17Anti-P/Q-type voltage-gated calcium channels antibody (Anti-P/Q VGCCs antibody)84

Na → Sodium (Na)17

P2 → Pregnanediol

42

N-acetyl glucosaminidase (NAG)

4P3 → Pregnanetriol

42

Index

Miller-Dieker syndrome (Chromosome 17) (Congenital anomaly)Index(Alphabet)

Index

P-Ⅲ-P → Procollagen Ⅲ peptide, CLIA

94

Plasmin-α2-plasmin inhibitor complex (PIC test)

32

PA → Prostate-specific antigen (PSA)

47

Anti-platelet antibody

87

PAIgG → Platelet associated Immunoglobulin G

87

Platelet associated Immunoglobulin G (PAIgG)

87

P-ANCA → Myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)

87

Platelet factor-4 (PF-4)

34

Pancreatic amylase → Amylase, type P, quantitative

3

Platelet surface marker analysis, CD41

108

Pancreatic glucagon

43

Platelet surface marker analysis, CD42b

108

Pancreatic phospholipase A2 (pancreatic PLA2)

3

Plg → Plasminogen

32

Parainfluenza virus, type 167

PML-RARA mRNA, qualitative

139

Parainfluenza virus, type 267

PML-RARA mRNA, quantitative

139

Parainfluenza virus, type 367

PML-RARA t(15;17) translocation

130

Parathyroid hormone (PTH), intact

37

PMS2→MMR protein, IHC

206

Parathyroid hormone (whole PTH)

37

PMS2→MMR protein, IHC (Lynch syndrome)

206

Parathyroid hormone related peptide (PTHrp)

37

Pneumocysis carinii (P.jirovecii)DNA

190

Anti-parietal cell antibody

82

POT method (Staphylococcus aureus)

183

Pathology specimen preparation (General materials)

196

Potassium (K)17

Pathology specimen preparation (Surgical materials)

196

PR3-ANCA → Serine proteinase3 anti-neutrophil cytoplasmic antibody

87

Pb → Lead (Pb)21

PRA → Plasma renin activity (PRA), EIA

44

PCA → Anti-parietal cell antibody

82

Prader-Willi syndrome→Chromosome 15 (Congenital anomaly)

125

128

PDGFRB 5q32 translocation

Prader-Willi syndrome→SNRPN gene analysis, Methylation-Specific PCR Prader-Willi syndrome Angelman syndrome

170

PD-L1 protein, IHC, 22C3

202､207

Prealbumin

91

PD-L1 protein, IHC, 28-8

202､207

Pregnanediol

42

PD-L1 protein, IHC, SP142

202､207

Pregnanetriol

42

PD-L1 protein, IHC, SP263

207

Presepsin

95

Pentratoxin 3 (PTX3)

92

PR-F → Protein fractionation1

Pepsinogen4

Primidone

25

Perampanel

25

Primron → Primidone

25

Periostin

215

PRL → Prolactin

36

Peripheral blood general test

30

Procainamide

27

Peripheral blood neutrophils BCR-ABL1 t(9;22) translocation

129

Procalcitonin95

PF-4 → Platelet factor-4 (PF-4)

34

Procollagen Ⅲ peptide (P-Ⅲ-P), CLIA

94

PG → Pepsinogen4

Procollagen type I N-propeptide (total P1NP)

93

PgR → Progesterone receptor, IHC

202

Pro-gastrin-releasing peptide (ProGRP)

48

Phenobal → Phenobarbital

24

Progesterone

41

Phenobarbital

24

Progesterone (IVF)

41

Phenytoin

24

Progesterone receptor, IHC

202

Philadelphia chromosome → BCR-ABL1 t(9;22) translocation

129

Prograf→ Tacrolimus

26

Philadelphia chromosome → Peripheral blood neutrophils BCR-ABL1 t(9;22) translocation

129

ProGRP → Pro-gastrin-releasing peptide (ProGRP)

48

Phospholipid

10

Prolactin

36

Phospholipid antibody → Anti-cardiolipin antibody, IgG

86

Pronon → Propafenone

27

Phospholipid antibody → Anti-cardiolipin antibody, IgM

86Propafenone

27

Phosphorylated tau protein

96

Propranolol

27

PIC test → Plasmin-α2-plasmin inhibitor complex (PIC test)

32

Prostate specific antigen (PSA)47

PIK3CA mutation analysis, SEQ

156

Prostate specific antigen (PSA), free/total ratio

47

Pilsicainide

27

Protein C (antigen level)

35

Pimenol → Pirmenol

28

Protein C activity

35

Pirmenol28

Protein fractionation

1

PIVKA-Ⅱ48

Protein S (antigen level)

35

PL → Anti-phospholipid antibody → Anti-cardiolipin β2 GP I complex antibody (Anti-CL-β2 GP I antibody)86

Protein S (free antigen level)

35

PL → Anti-phospholipid antibody → Lupus-anticoagulant, APTT clotting time

85

Protein S activity

35

PL → Anti-phospholipid antibody → Lupus-anticoagulant, Diluted Russell's viper venom time test

85

Protein, total (TP), 24-hour urine

1

PL → Anti-phospholipid antibody → Lupus-anticoagulant, Phospholipid neutralization method

85

Protein, total (TP), CSF

1

PL → Anti-phospholipid antibody → Anti-cardiolipin antibody, IgG

86

Protein, total (TP), serum1

PL → Anti-phospholipid antibody → Anti-cardiolipin antibody, IgM

86Anti-prothrombin antibody

218

PL → Anti-phospholipid antibody → Anti-β2 glycoprotein Ⅰ antibody, IgG

86Prothrombin fragment F1+2

32

PL → Anti-phospholipid antibody → Anti-β2 glycoprotein Ⅰ antibody, IgM

86Prothrombin time (PT)32

PLA2 → Pancreatic phospholipase A2 (pancreatic PLA2)

3

Protoporphyrin

19

Placental alkaline phosphatase (PLAP)

2

Provirus → HTLV-I (ATLV) provirus DNA (Clonality)70

PLAP → Placental alkaline phosphatase (PLAP)2

PRRT2 gene mutational analysis

171

Plasma renin activity (PRA), EIA

44

PSA → Prostate specific antigen (PSA), free/total ratio

47

Plasminogen

32

PSA → Prostate-specific antigen (PSA)

47

Index(Alphabet)

PT fragment F1+2 → Prothrombin fragment F1+2

32

PT→Prothrombin time (PT)32

PTH→Parathyroid hormone (PTH), intact

37

SAA → Amyloid A protein, Serum (SAA)92

PTH→Parathyroid hormone (whole PTH)

37

Salicylates

29

PTHrP → Parathyroid hormone related peptide (PTHrP)37

Sandimmun → Cyclosporine

26

PTX3 → pentraxin 3 (PTX3)

92

SCC

46

Pulmonary surfactant protein A (SP-A)

14

SCCA2

98

Pulmonary surfactant protein D (SP-D)

14

Anti-Scl-70 antibody

80

Pyrinazin → Acetaminophen

29

Screening of chimeric genes related to leukemia, quantitative

136

Pyruvic acid9

sd LDL-C, physical examination

12

sd LDL-cholesterol

10

Selenica R → Valproate

25
28

page

page

Q-band → Chromosome (Congenital anomaly)

124

Serenase → Haloperidol

QT → Congenital long QT syndrome gene analysis

173

Serine proteinase3 anti-neutrophil cytoplasmic antibody (PR3-ANCA)

87

Qualitative detection of ROS1 gene fusions

153

Serological typing (HLA-A, B)

175

Qualitative detection of ROS1 gene fusions (FFPE)

153

Serological typing (HLA-DR)

175

Quinidine28

Serotonin

40

Quinidine sulfate → Quinidine

28

Sex-mismatched bone marrow transplantation (BMT) (Chromosome XY)

131

sFlt-1/PlGF ratio

45

R

page

SFMC → Soluble fibrin monomer complex (SFMC)

32125

RAS gene mutational analysis, BEAMing

157

SHOX → Chromosomes XY (Short stature homeobox [SHOX])

RAS/BRAF mutational analysis

157

Sialic acid8

RBP → Retinol binding protein (RBP)

91

Sialyl Lewisx antigen (CSLEX)

46

Remnant-like particles-cholesterol (RLP-C)

10

Sialyl Lewisx-i antigen (SLX)

46

Renin concentration (ARC), CLEIA

44

Sialyl Tn antigen (STN)46

RET gene mutation analysis, Medullary carcinoma of the thyroid

170

Sialylated carbohydrate antigen KL-6 → KL-6

95

Reticulocyte count

30

Simultaneous identification of DNA of N. gonorrhoeae and C. trachomatis

191

Retinol binding protein (RBP)

91

Anti-skin antibody

218

RF (Rheumatoid factor), quantitative

82

Single site analysis for RET

170

Rh (D) blood group test

88

Single site testing for BRCA1/2 gene

168

Rheumatoid factor (RF), quantitative

82

Skin autoantibody (direct method)87

Rheumatoid factor, IgG

82

SKY → Chromosome analysis using spectral karyotyping (SKY) (Congenital anomaly)

124

Rh-Hr type88

SKY → Chromosome analysis using spectral karyotyping (SKY) (Hematological disorder)

127

Ri autoantibody

223

SLX → Sialyl Lewisx-i antigen (SLX)46

Rickettsia tsutsugamushi, Gilliam, IgG

78

Anti-Sm antibody

80

Rickettsia tsutsugamushi, Gilliam, IgM

78

SM-C → IGF-1 (Somatomedin C)

36

Rickettsia tsutsugamushi, Karp, IgG

78

Sm-Ig (B-cell surface immunoglobulin)

108

Rickettsia tsutsugamushi, Karp, IgM

78

Anti-smooth muscle antibody

82

Rickettsia tsutsugamushi, Kato, IgG

78

SNRPN gene analysis, Methylation-Specific PCR Prader-Willi syndrome Angelman syndrome

170

Rickettsia tsutsugamushi, Kato, IgM

78

Sodium (Na)17

Rislamid R → Disopyramide

27

Soluble fibrin monomer complex (SFMC)

32

Ristocetin cofactor (von Willebrand factor activity)

33

Soluble fms-like tyrosine kinase-1 (sFlt-1)/Placental growth factor (PlGF) ratio

45

Rivotril → Clonazepam

24

Soluble IL-2 receptor (sIL-2R)

97

RLP-C → Remnant-like particles-cholesterol (RLP-C)

10

Soluble mesothelin related peptide

48

Anti-RNA polymerase Ⅲ antibody

80

Somatomedin C (IGF-1)

36

Anti-RNP antibody

80

Sotos syndrome→Chromosome 5 (Congenital anomaly)124

RPR → Syphilis serology test, quantitative, RPR

77

SPan-146

RS virus, CF

67

SP-A → Pulmonary surfactant protein A (SP-A)

14

RS virus, NT

67

SP-D → Pulmonary surfactant protein D (SP-D)

14

Rubella virus

66

Specific IgE (Ara h 2) (Peanut-derived)

98

Rubella virus IgG

66

Specific IgE (C-PAC5 allergens) for children’s elimination diet98

Rubella virus IgM

66

Specific IgE (C-PAC16 allergens) for atopic dermatitis

98

Rufinamide

25

Specific IgE (C-PAC16 allergens) for children

98

RUNX1-MECOM mRNA, qualitative

141

Specific IgE (C-PAC16 allergens) for rhinitis/asthma

98

RUNX1-RUNX1T1 (AML1-MTG8) t(8;21) translocation

129

Specific IgE (MAST 36 allergens)

98

RUNX1-RUNX1T1 mRNA, qualitative

140

Specific IgE (MAST 48mix)

98

RUNX1-RUNX1T1 mRNA, quantitative

140

Specific IgE (mixed allergens) Animal panel 2

99

Rythmodan → Disopyramide

27

Specific IgE (mixed allergens) Eumycetes panel

99

Specific IgE (mixed allergens) Food panel 7

99

Specific IgE (mixed allergens) Food panel 4

99

Index

Q

S

Index(Alphabet)

Index

Specific IgE (mixed allergens) Grass family panel 599

T-cell receptor β-chain Cβ1 rearrangement

149

Specific IgE (mixed allergens) Weeds panel 599

T-cell receptor β-chain Jβ1 rearrangement

149

Specific IgE (multi-allergens) Animal epithelium

100

T-cell receptor β-chain Jβ2 rearrangement

149

Specific IgE (multi-allergens) Foods

100

T-cell receptor γ-chain Jγ rearrangement

149

Specific IgE (multi-allergens) Grains

100

T-cell receptor δ-chain Jδ1 rearrangement

149

Specific IgE (multi-allergens) Grass family

100

TCF3/PBX1 t(1;19) translocation

127

Specific IgE (multi-allergens) Mold

100

TCF3-PBX1 mRNA, qualitative

139

Specific IgE (multi-allergens) Weeds

100

TCF3-PBX1 mRNA, quantitative

139

Specific IgE (single allergen)

98

T-Cho → Cholesterol, total (T-Cho)

10

Specific IgE (View allergies 39)

98

Tegretol → Carbamazepine

24

Specific tests of common bacteria

183

Teicoplanin

23

Sperm immobilizing antibody

85

Telesmin → Carbamazepine

24

Sperm immobilizing antibody (SI50)

85

Testosterone

42

Spinocerebellar degeneration gene analysis

172

Testosterone, free RIA

42

Squamous cell carcinoma associated antigen → SCC

46

Tetanus toxin antibody

218

SRY → Chromosome Y (Sex determining region Y [SRY])125

Tf → Transferrin

92

Anti-ss DNA antibody, IgG

80

Tf → Transferrin, Urine

92

Anti-ss DNA antibody, IgM

80

Tf → Transferrin, Urine (creatinine ratio)

92

Anti-SS-A/Ro antibody

80

Tg → Thyroglobulin, CLEIA

37

Anti-SS-B/La antibody

80

TG → Triglycerides (TG)10

SSEA-1 antigen → Sialyl Lewisx-i antigen (SLX)46

TgAb → Anti-thyroglobulin antibody, CLEIA84

Stained specimen preparation

196

Th1/Th2 (IFN-γ×IL-4/CD4)108

Staphylococcus aureus-related test

183

Th2 chemokine (TARC)

97

STIL-TAL1 mRNA, quantitative

143

Theodur → Theophylline

29

Stiripentol

25

Theolong → Theophylline

29

STN → Sialyl Tn antigen

46

Theophylline

29

Anti-streptolysin-O antibody (ASO)76

Thrombin/Antithrombin complex Ⅲ (TAT)32

Stromelysin-1 → MMP-3 (Matrix metalloproteinase 3)

4

Thrombomodulin

35

STS-RPR → Syphilis serology test, quantitative, RPR

77

Thymidine kinase activity

35

Styrene metabolites, Urine

20

Thyroglobulin, CLEIA

37

Sugar metabolism analysis

8Anti-thyroglobulin antibody, CLEIA

84

Sulfatide autoantibody (IgG, IgM)

221

Anti-thyroid peroxidase antibody (Anti-TPO antibody), CLEIA

84

Sunrythm → Pilsicainide

27

Thyroid stimulating antibody (TSAb)

84

Surgical materials

196

Thyroid stimulating hormone (TSH), CLEIA, IFCC

36

Susceptibility test for acid-fast bacteria [MIC]185

Thyroxine (T4), CLEIA

37

Susceptibility test for Mycobacterium tuberculosis [MIC]185

Thyroxine binding globulin (TBG)

37

Susceptibility test of Helicobacter

183

TIBC → Total iron binding capacity (TIBC)

18

Susceptibility testing181

Anti-TIF1-γ antibody

82

Syphilis serology test, qualitative77

Tissue polypeptide antigen (TPA)

47

Syphilis serology test, quantitative77

TK activity → Thymidine kinase activity

35

Syphilis serology test, quantitative RPR, LA

77

TM → Thrombomodulin

35

TNF-α (High sensitivity tumor necrosis factor α)

215

T

page

TnT → Myocardial troponin T

92

T cell percentage B cell percentage

108

Tobracin → Tobramycin

23

T cell percentage/IgG-FcR+

108

Tobramycin

23

T3 → Triiodothyronine (T3), CLEIA

37

Topina → Topiramate

25

T4 → Thyroxine (T4), CLEIA

37

Topiramate

25

Tacrolimus

26

Anti-Topoisomerase 1 Antibody → Anti-Scl-70 antibody

80

TACSTD2 Gene analysis (cornea dystrophy)

172

Total iron binding capacity (TIBC)

18

Tambocor → Flecainide

28

total P1NP → Procollagen type I N-propeptide (total P1NP)

93

TARC → Th2 chemokine (TARC)

97

Total PAI-1(tPA/PAI-1 complex)

32

Targocid → Teicoplanin

23

Toxic shock syndrome toxin-1 productivity

183

Tartrate resistant acid phosphatase (TRACP-5b)

3

Toxoplasma antibody, lgG

79

TAT→Thrombin/Antithrombin complex Ⅲ

32

Toxoplasma antibody, lgM

79

Tau protein

96

TP → Protein, total (TP), 24-hour urine

1

Tau protein, total (AD)216

TP → Protein, total (TP), CSF

1

TB → Bilirubin, total (T-Bil)

19

TP → Protein, total (TP), serum

TBA → Bile acids, total

13

TP53 17p deletion

130

TBG → Thyroxine binding globulin (TBG)

37

TPA → Tissue polypeptide antigen (TPA)

47

TCA → Trichloroacetic acid, Urine

20tPA/PAI-1 complex (Total PAI-1)

32

1

Index(Alphabet)

1

TPHA → Treponema pallidum, quantitative, TPHA

77

Anti-TPO-Ab → Anti-thyroid peroxidase antibody (Anti-TPO antibody), CLEIA

84

Anti-transcriptional intermediary factor 1-γ (TIF1-γ) antibody

82

Valerin → Valproate

25

Transferrin

92

Valproate

25

Transferrin, Urine

92

Vancomycin

23

Transferrin, Urine (creatinine ratio)

92

Vancomycin, hydrochloride

23

Transthyretin → Prealbumin

91

Vanillylmandelic acid → VMA

40

Treponema pallidum, qualitative TP antibody, LA

77

Varicella-zoster virus

57

Treponema pallidum, quantitative

77

Varicella-zoster virus antigen, FA

57

Trichloro compounds, Urine, total

20

Varicella-zoster virus DNA, qualitative

57

Trichloroacetic acid, Urine

20

Varicella-zoster virus DNA, quantitative

57

Trichosporon asahii antibody

79

Varicella-zoster virus IgG

57

Triglycerides (TG)10

Varicella-zoster virus IgM

57

Triiodothyronine (T3), CLEIA

37

Ventricle myosin light chain I

92

Trimethadione

25

Very long chain fatty acid12

Trypsin3

Vfend → Voriconazole

23

TSAb→Thyroid stimulating antibody (TSAb)

84

Viable cell count, Urine quantitative

181

TSBAb (TSH receptor antibody [blocking type]), Bioassay

215

View allergies 39→Specific IgE

98

TSH → Thyroid stimulating hormone (TSH), CLEIA, IFCC

36

Vimpat → Lacosamide25

TSH receptor antibody, CLEIA

84

Viruses identification

192

TSH receptor antibody, quantitative

84

Viruses isolation

192

T-SPOT → Tuberculosis specific IFN-γ

79

Vitamin A

15

TTC → Trichloro compounds, Urine, total

20

Vitamin B1

15

TTR gene analysis (Familial amyloidosis)

171

Vitamin B2

15

Tuberculosis specific IFN-γ

79

Vitamin B6

15

TV/MG→Detection of Trichomonas vaginalis (TV) and Mycoplasma genitalium (MG) DNA

191

Vitamin B12

15

Two-color CD4/CD8

110

Vitamin C (ascorbic acid)16

Two-color CD4/CD25

110

Vitamin E

16

Two-color CD4/CD29

110

Vitamin E fractionation

16

Two-color CD4/CD45RA

110

Vitamin K fractionation

16

Two-color CD11b/CD8

110

VMA → Vanillylmandelic acid40

Two-color CD16/CD56

110

von Willebrand factor activity (ristocetin cofactor)

33

Two-color CD20/CD5

110

von Willebrand factor antigen assay

33

Two-color CD45RO/CD4110

von Willebrand factor multimer analysis

33

Two-color CD57/CD16110

Voriconazole

23

Two-color HLA-DR/CD3

110vWF → von Willebrand factor

33

Two-color HLA-DR/CD4110

VZV → Varicella-zoster virus

57

Two-color HLA-DR/CD8110

VZV → Varicella-zoster virus IgG

57

VZV → Varicella-zoster virus IgM

57

VZV antigen→ Varicella-zoster virus antigen, FA

57

U

page

Uterine cervical cancer PD-L1 protein, IHC, 22C3

V

202
page

UA → Uric acid6

VZV DNA → Varicella-zoster virus DNA, qualitative

57

ucOC → Undercarboxylated osteocalcin (ucOC)45

VZV DNA → Varicella-zoster virus DNA, quantitative

57

UGT1A1 gene polymorphism analysis

174

UIBC → Unsaturated iron binding capacity (UIBC)

18

W

page

UN → Urea nitrogen

6

Wakobital → Phenobarbital

Undercarboxylated osteocalcin (ucOC)

45

whole PTH → Parathyroid hormone (whole PTH)

37

Uniphyl → Theophylline

29

Williams syndrome→Chromosome 7 (Congenital anomaly)124

Unsaturated iron binding capacity (UIBC)

18

Wolf-Hirschhorn syndrome→Chromosome 4 (Congenital anomaly)

124

Unstained specimen preparation

196

WT1 mRNA quantitative

136

Urea nitrogen (UN)6

Uric acid (UA)

6

X

24

page

Urinalysis

178

X-Chromosome (Congenital anomaly)

125

Urine cytodiagnosis (LBC)193

X-Chromosome (Hematological disorder)

131

Urine immunoelectrophoresis, Bence Jones protein identification

90

X-Chromosome (Steroid sulfatase [STS] gene)

125

Urine NGAL93

XY-Chromosomes (Short stature homeobox [SHOX])

125

Urine protein fractionation1

Xylocaine → Lidocaine

27

Uroporphyrin

19

Uroporphyrin, urine

19

UroVysion → Bladder cancer FISH (UroVysion)

193

Y
Y chromosome microdeletion (AZF region)

page
173

Index

TP-F → Protein fractionation

Index(Alphabet)

Index

Y-Chromosome (Congenital anomaly)

125

Y-Chromosome (Hematological disorder)

131

Y-Chromosome (Sex-determining region Y [SRY])125

Yo autoantibody

223

Z

page

Zarontin → Ethosuximide

24

Zinc (Zn)18

Zinc sulfate turbidity test (ZTT, Kunkel)

1

Zinc transporter 8 (ZnT8) antibody

84

Zn → Zinc

18

ZnT8 antibody

84

Zonisamide

25

ZTT, Kunkel → Zinc sulfate turbidity test (ZTT, Kunkel)

1Index(Greek letter）（Number)
Greek letter
page

page

α1-acidglycoprotein

91

1,25-(OH)2 Vitamin D

α1AG → α1-acidglycoprotein

91

1,5 anhydro-D-glucitol (1,5 AG)

α1-Antitrypsin91

1p Deletion132

α1AT → α1-Antitrypsin

91

1p36 deletion syndrome → Chromosome 1124

α1-M → α1-Microglobulin

91

2,5-hexandione, Urine20

α1-Microglobulin

91

Factor Ⅱ, Coagulation factor activity test

33

α2 plasmin inhibitor → Antiplasmin(α2 plasmin inhibitor)

32

3-Methoxy-4-Hydroxyphenylglycol (MHPG)40

α2-macroglobulin

91

5-HT → Serotonin

40

α-fetoprotein, quantitative

46

5-Hydroxyindoleacetic Acid (5-HIAA)

40

α-hANP → Human atrial natriuretic peptide (HANP)

45

5-S-cysteinyldopa (5-S-CD)

47

β

page

16
8

Factor Ⅴ, Coagulation factor activity test

33

7AAD analysis, Malignant lymphoma analysis

105

Anti-β2 glycoprotein Ⅰ antibody, IgG

86Factor Ⅶ, Coagulation factor activity test

33

Anti-β2 glycoprotein Ⅰ antibody, IgM

868-color→Multiple myeloma multiparameter flow cytometry (8-color)105

β2 -microglobulin

92

Factor Ⅷ, Coagulation factor activity test

33

β2GP I antibody → Anti-cardiolipin β2 GP I complex antibody

86

Factor Ⅷ, Coagulation inhibitor identification

33

β-Amyloid 1-42/1-40 ratio

96

Factor Ⅸ, Coagulation factor activity test

33

β-carotene

15

Factor Ⅸ, Coagulation inhibitor identification

33

β-D-glucan

78

Factor Ⅹ, Coagulation factor activity test

33

β-lipoprotein

13

11-hydroxycorticosteroids → Blood 11-OHCS

38

β-thromboglobulin (β-TG)

34

Factor Ⅺ, Coagulation factor activity test

33

12 inhalation allergens (Atopy screening test)

98

Factor Ⅻ, Coagulation factor activity test

33
33

γ

page

γ-aminobutyric acid (GABA)

8

Factor , Coagulation factor activity test

γ-GT (γ-GTP)

217α-hydroxyprogesterone

38

γ-seminoprotein (γ-Sm)

47

19q Deletion132

20q deletion, FISH

131

25-hydroxyvitamin D (Rickets/Osteomalacia)

16

25OH vitamin D (Osteoporosis)

16δδ-aminolevulinic acid (δALA)

page
19

Index

α

Number